Replay available

BillionToOne, Inc. (BLLN) Q2 2026 Earnings Call

BillionToOne, Inc. (NASDAQ: BLLN) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

Wed, August 5, 2026 at 4:30 PMendedReplay
BillionToOne, Inc. (BLLN) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Gabby Gable

Investor Relations

Oguzhan Atay

Co-Founder & Chief Executive Officer

Ross Taylor

Chief Financial Officer

Mark Massaro

Analyst, BTIG

Dan Arias

Analyst, Stiefel

Subbu Nambi

Analyst, Guggenheim

Tycho Peterson

Analyst, Jefferies

David Westenberg

Analyst, Piper Sandler

Casey Woodring

Analyst, J.P. Morgan

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Billion to One Second Quarter 2026 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised, today's conference is being recorded. I would now like to turn the conference over to your speaker today, Gabby Gable, Investor Relations. Please go ahead. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from BillionToOne, we have Oguzhan Atay, co-founder and chief executive officer, and Ross Taylor, chief financial officer. Earlier today, BillionToOne released financial results for the second quarter ended June 30, 2026. A copy of the press release is available on the company's website. Before we begin, I want to remind you that during this call, we may make forward-looking statements within the meaning of federal securities laws. Such statements about future events may include statements about our financial outlook and performance, market size, our products and services, reimbursement coverage, future clinical performance, and other similar statements. We caution you that such statements reflect our current best judgment and actual results may differ materially from those expressed or implied in any forward looking statements. Risk factors that may cause our results to differ are discussed in our filings with the SEC, including our previously filed annual report on Form 10-K, our quarterly report on Form 10-Q to be filed following this call, an...

More from Billiontoone, Inc.